74 related articles for article (PubMed ID: 38765304)
1. Walking impairment in patients with multiple sclerosis - a new therapeutic approach and clinical potential of dalfampridine extended release tablets.
Henney HR; Blight AR
Degener Neurol Neuromuscul Dis; 2012; 2():53-64. PubMed ID: 30890878
[TBL] [Abstract][Full Text] [Related]
2. Effects of Physical Therapy and Dalfampridine on Function and Quality of Life in Nonambulatory Individuals With Multiple Sclerosis: A Randomized Controlled Trial.
Bromley LE; Weinstock-Guttman B
Int J MS Care; 2024; 26(3):98-103. PubMed ID: 38765304
[TBL] [Abstract][Full Text] [Related]
3. Dalfampridine benefits ambulation but not cognition in multiple sclerosis.
Satchidanand N; Drake A; Smerbeck A; Hojnacki D; Kolb C; Patrick K; Weinstock-Guttman B; Motl R; Benedict RH
Mult Scler; 2020 Jan; 26(1):91-98. PubMed ID: 30566030
[TBL] [Abstract][Full Text] [Related]
4. Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot Study.
Plummer P; Markovic-Plese S; Giesser B
Front Rehabil Sci; 2021; 2():795306. PubMed ID: 36188834
[No Abstract] [Full Text] [Related]
5. Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial.
Applebee A; Goodman AD; Mayadev AS; Bethoux F; Goldman MD; Klingler M; Blight AR; Carrazana EJ
Clin Ther; 2015 Dec; 37(12):2780-7. PubMed ID: 26565077
[TBL] [Abstract][Full Text] [Related]
6. Dalfampridine effects on cognition, fatigue, and dexterity.
Korsen M; Kunz R; Schminke U; Runge U; Kohlmann T; Dressel A
Brain Behav; 2017 Jan; 7(1):e00559. PubMed ID: 28127507
[TBL] [Abstract][Full Text] [Related]
7. Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis.
Dunn J; Blight A
Curr Med Res Opin; 2011 Jul; 27(7):1415-23. PubMed ID: 21595605
[TBL] [Abstract][Full Text] [Related]
8. Modifying the five-time sit-to-stand test to allow use of the upper limbs: Assessing initial evidence of construct validity among lower limb prosthesis users.
Gaunaurd IA; Morgan SJ; Balkman GS; Kristal A; Rosen RE; Haynes JS; Gailey RS; Hafner BJ
PLoS One; 2023; 18(2):e0279543. PubMed ID: 36763586
[TBL] [Abstract][Full Text] [Related]
9. How patients with multiple sclerosis acquire disability.
Lublin FD; Häring DA; Ganjgahi H; Ocampo A; Hatami F; Čuklina J; Aarden P; Dahlke F; Arnold DL; Wiendl H; Chitnis T; Nichols TE; Kieseier BC; Bermel RA
Brain; 2022 Sep; 145(9):3147-3161. PubMed ID: 35104840
[TBL] [Abstract][Full Text] [Related]
10. Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials.
Zhang E; Tian X; Li R; Chen C; Li M; Ma L; Wei R; Zhou Y; Cui Y
Orphanet J Rare Dis; 2021 Feb; 16(1):87. PubMed ID: 33588903
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.
Benedict RHB; Amato MP; DeLuca J; Geurts JJG
Lancet Neurol; 2020 Oct; 19(10):860-871. PubMed ID: 32949546
[TBL] [Abstract][Full Text] [Related]
12. Treatment and management of cognitive dysfunction in patients with multiple sclerosis.
DeLuca J; Chiaravalloti ND; Sandroff BM
Nat Rev Neurol; 2020 Jun; 16(6):319-332. PubMed ID: 32372033
[TBL] [Abstract][Full Text] [Related]
13. Exercise and Multiple Sclerosis.
Motl RW
Adv Exp Med Biol; 2020; 1228():333-343. PubMed ID: 32342468
[TBL] [Abstract][Full Text] [Related]
14. Trajectories of Symbol Digit Modalities Test performance in individuals with multiple sclerosis.
Healy BC; Barker L; Bakshi R; Benedict RHB; Gonzalez CT; Chitnis T; Weiner HL; Glanz BI
Mult Scler; 2021 Apr; 27(4):593-602. PubMed ID: 32228283
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
